Compare Stocks → The Hard Truth About Investing For Retirement (From Insiders Exposed) (Ad) Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS). Comparison Ideas Agriculture StocksAirline StocksApparel StocksArtificial Intelligence StocksAutomotive StocksBank StocksBitcoin StocksBlockchain StocksCanadian StocksCannabis StocksCasino StocksChatGPT StocksChinese StocksCloud Storage StocksCoronavirus Therapeutics StocksCryptocurrency StocksCybersecurity StocksDefense StocksDividend StocksDow 30 StocksEcommerce StocksElectric Vehicles StocksEnergy StocksEntertainment StockseSports StocksEV Charging StocksFertilizer StocksGold StocksGrocery StocksGrowth StocksHealthcare StocksHigh Dividend StocksHome Office StocksHotel StocksLarge Cap StocksLeisure StocksLithium StocksMagnificent Seven StocksMATANA StocksMega Cap StocksMeme StocksMetaverse StocksMid Cap StocksMining StocksMusic Industry StocksNanotechnology StocksNFT StocksOil StocksOutdoor Activities StocksPharmaceutical StocksRenewable Energy StocksRestaurant StocksRetail StocksSemiconductor StocksSocial Media StocksSolar StocksSpace StocksStay-At-Home StocksTechnology StocksTelecom StocksToy StocksUtility StocksVaccine StocksVideo Game StocksVirtual Reality StocksWallStreetBets Stocks Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare Share Comparison Share Comparison NASDAQ:EYE Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Stocks - Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeEYENational Vision$18.44-1.8%$21.34$13.71▼$27.02$1.47B1.39940,861 shs813,048 shsInvesting Strategies To Help Grow Your Retirement IncomeNeed to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.Get This Free ReportPrice PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceEYENational Vision-1.81%-4.06%-16.71%-1.91%-10.05%The Hard Truth About Investing For Retirement (Ad)Here’s the cold, hard truth about investing: The more capital you have, the more risk averse you can afford to be. But when you’re staring down the barrel of retirement and you’ve only got 5, 10, 50 or $100,000 saved, you’ve got to be more aggressive. In an exclusive online training, the Market expert Steven Place is revealing a powerful “roadmap” that’s leading everyday investors to easy, triple-digit wins, even if they don’t have a lot of experience in trading.Click To Access This Powerful Training Right Now!MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationEYENational Vision3.5168 of 5 stars3.02.00.03.32.30.01.9Analyst RatingsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceEYENational Vision2.00Hold$23.8629.38% UpsideCurrent Analyst RatingsLatest DEV, 9SP, LNU, and EYE Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails2/28/2024EYENational VisionThe Goldman Sachs GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetNeutral ➝ Neutral$18.00 ➝ $20.00(Data available from 4/23/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookEYENational Vision$2.13B0.68$1.73 per share10.67$10.60 per share1.74Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateEYENational Vision-$65.90M-$0.85N/A39.234.22-3.10%3.69%1.41%5/9/2024 (Estimated)Latest DEV, 9SP, LNU, and EYE EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails2/27/202412/31/2023EYENational Vision-$0.09-$0.02+$0.07$0.06$499.49 million$506.40 million DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthEYENational VisionN/AN/AN/AN/AN/ADebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioEYENational Vision0.541.000.70OwnershipInstitutional OwnershipCompanyInstitutional OwnershipEYENational VisionN/AInsider OwnershipCompanyInsider OwnershipEYENational Vision2.10%MiscellaneousCompanyEmployeesShares OutstandingFree FloatOptionableEYENational Vision13,99878.31 million76.67 millionOptionableDEV, 9SP, LNU, and EYE HeadlinesSourceHeadlineTime Is Running Out for Rahul Gandhi’s Vision for Indianytimes.com - April 20 at 9:34 AMI Can See Clearly Now: Eye Care for Seniors Begins at 50baltimoretimes-online.com - April 19 at 2:25 PMCountdown to Paris Olympics: Americans Eye Sponsored Gear To Show National Pride Ahead of Summer Gamescivicscience.com - April 18 at 12:22 AMPartnership, in all its forms, can reduce the prevalence of vision impairment and help people in the region see better.channelnewsasia.com - April 18 at 12:22 AMVitrea Launches Macular Support: A New Product in Eye Health Nutrition and AMD Preventionnews.marketersmedia.com - April 17 at 9:19 AMAllspring Global Investments Holdings LLC Acquires 72,318 Shares of National Vision Holdings, Inc. (NASDAQ:EYE)marketbeat.com - April 17 at 5:00 AMBulging Eyes, Feeling Irritation In The Eye? It Could Be Thyroid Eye Diseaseonlymyhealth.com - April 15 at 12:42 PMGrand National 2024 racegoers steal spotlight in eye-catching outfits as the sun shines at Aintreethesun.co.uk - April 13 at 12:43 PMKindle for iPad now works on the Apple Vision Progoodereader.com - April 12 at 10:43 AMSeeing spots after the eclipse? If they don’t go away, see your eye doctorajc.com - April 11 at 11:16 PMHow to tell if you have eye damage after viewing the eclipsewtop.com - April 11 at 11:16 PMPH, US, Japan eye more combined naval training and exercisesmsn.com - April 11 at 11:16 PMDriving at night can get harder starting as early as your late 20s. Here’s how to improve nighttime vision.msn.com - April 11 at 11:16 PMEye injuries surge following solar eclipse: ‘Damage can be irreversible’msn.com - April 11 at 1:15 PMA Real Life Eye of Sauron? New Technology To Detect Airborne Threats Instantlyscitechdaily.com - April 11 at 8:15 AMNational Vision (NASDAQ:EYE) Trading Down 8.2%marketbeat.com - April 10 at 3:46 PMIf your eyes hurt after watching the solar eclipse, here's what you need to knowbusinessinsider.com - April 10 at 10:10 AMMan whose eye was ‘protruding from head’ says he visited hospitals nine times before cancer diagnosismanchestereveningnews.co.uk - April 9 at 6:58 PMVision doctors urge people to have their eyes checked following eclipsekyma.com - April 9 at 6:58 PMLondon athlete who suddenly lost sight earns national blind hockey team spotlfpress.com - April 9 at 8:57 AM“We are now in an eye health emergency”aop.org.uk - April 9 at 8:57 AMJohns Hopkins University: Wilmer Eye Institute Receives Over $20 Million for Clinical Trial Investigating Genetic Eye Conditionindiaeducationdiary.in - April 9 at 3:57 AMSymptoms of eye damage from looking at a solar eclipse might not appear for hoursmsn.com - April 9 at 3:57 AMDid you look at the solar eclipse too long? Doctors explain signs of eye damagemsn.com - April 8 at 5:56 PMNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop HeadlinesNvidia's AI Tech Part of Novo Nordisk's New Supercomputer March 24, 2024 1:50 PMView Nvidia's AI Tech Part of Novo Nordisk's New Supercomputer 2 Data Storage Device Stocks Thriving From the AI BoomApril 2, 2024 7:25 AMView 2 Data Storage Device Stocks Thriving From the AI BoomAkebia Therapeutics Surges on FDA Approval for Anemia TreatmentApril 3, 2024 9:10 AMView Akebia Therapeutics Surges on FDA Approval for Anemia TreatmentDexCom Stock Gains from GLP-1 Diabetic UsersApril 2, 2024 7:16 AMView DexCom Stock Gains from GLP-1 Diabetic UsersSilicon Motion Proves That AI in Motion Stays in MotionApril 16, 2024 11:42 AMView Silicon Motion Proves That AI in Motion Stays in MotionAll Headlines Company DescriptionsNational VisionNASDAQ:EYENational Vision Holdings, Inc., through its subsidiaries, operates as an optical retailer in the United States. The company operates in two segments, Owned & Host and Legacy. It offers eyeglasses and contact lenses, and optical accessory products; provides eye exams through its America's Best, Eyeglass World, Vista Optical, Fred Meyer, and Vista Optical military, as well as Vision Center branded stores; and offers health maintenance organization and optometric services. National Vision Holdings, Inc. was founded in 1990 and is headquartered in Duluth, Georgia. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.